Both in Biotechnology
4D Molecular Therapeutics vs Aura Biosciences
Over the past year FDMT returned +1.3% and AURA returned −0.2%; their daily moves had a correlation of 0.35.
FDMT +1.3% AURA −0.2%Growth of $1, one year, split-adjusted
| Metric | FDMT | AURA |
|---|---|---|
| Price | $11.37 | $6.03 |
| Market cap | $628.1M | $625.3M |
| Today | −4.45% | −1.79% |
| 1 month | −16.8% | −1.0% |
| 6 months | +20.4% | −27.8% |
| Year to date | +51.6% | +10.6% |
| 1 year | +0.4% | −0.8% |
| Revenue growth (YoY) | +25106.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −1929.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.8× | — |
| Net cash | $341.7M | $323.8M |
| Dividend yield | — | — |
| Volatility (60d) | 75.9% | 41.0% |
| Short % of float | 21.6% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).